Sign in

CIK 0001851484 · <br>Emerging growth company

CITIUS ONCOLOGY, INC.

Sign in to watch
Ticker
CTOR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
994362660
Phone
(908) 967-6677
Business address
11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
Former names
TenX Keane Acquisition
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  7. 4/A Grant or award Secretary acquired 850,000 shares (grant or award)
  8. 4/A Grant or award Chief Medical Officer acquired 825,000 shares (grant or award)
  9. 4/A Grant or award Chief Financial Officer acquired 825,000 shares (grant or award)
  10. 4/A Grant or award Chief Executive Officer acquired 1,700,000 shares (grant or award)
  11. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  12. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  13. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  14. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  15. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  16. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  17. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  18. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  19. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  20. 4/A Grant or award Chief Financial Officer acquired 825,000 shares (grant or award)

Page 1 of 4 · 74 filings